Madeleine Carreau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Madeleine Carreau has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Caroline C. Huard
Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada
5 shared publications Georges Lévesque
Department of Psychiatry and Neurosciences, Université Laval, Cité Universitaire, Québec, Canada
5 shared publications- Cedric S. Tremblay
University of Manitoba
4 shared publications Audrey Magron
CHU de Québec, CHUL Research Center, Québec, QC, Canada
3 shared publicationsOuassila Habi
Unité de Recherche en Pédiatrie, Department of Pediatrics, Université Laval, CHUQ-CHUL, RC-9800, 2705 Boulevard Laurier, Québec, QC, Canada G1V 4G2
3 shared publicationsChantal Godin
Department of Psychiatry and Neurosciences, Université Laval, Cité Universitaire, Québec, Canada
2 shared publications
Latest Publications
- Open Access
- 12 September 2018
- Published by Springer Nature in BMC Research Notes
- Vol. 11 (1) , 662
FANCC localizes with UNC5A at neurite outgrowth and promotes neuritogenesis
The Uncoordinated 5A (UNC5A) protein is part of a family of receptors that play roles in axonal pathfinding and cell migration. We previously showed that the Fanconi anemia C protein (FANCC) interacts with UNC5A and delays UNC5A-mediated apoptosis. FANCC is a predominantly cytoplasmic protein that has multiple functions including DNA damage signaling, oxygen radical metabolism, signal transduction, transcriptional regulation and apoptosis. Given the direct interaction between FANCC and UNC5A and that FANCC interferes with UNC5A-mediated apoptosis, we explored the possibility that FANCC might play a role in axonal-like growth processes. Here we show that FANCC and UNC5A are localized to regions of neurite outgrowth during neuronal cell differentiation. We also show that absence of FANCC is required for neurite outgrowth. In addition, FANCC seems required for UNC5A expression. Results from this study combined with our previous report suggest that FANCC plays a role in tissue development through the regulation of UNC5A-mediated functions.
- 12 September 2018
- Published by Springer Nature in BMC Research Notes
- Vol. 11 (1) , 662
Open AccessFANCC localizes with UNC5A at neurite outgrowth and promotes neuritogenesis
The Uncoordinated 5A (UNC5A) protein is part of a family of receptors that play roles in axonal pathfinding and cell migration. We previously showed that the Fanconi anemia C protein (FANCC) interacts with UNC5A and delays UNC5A-mediated apoptosis. FANCC is a predominantly cytoplasmic protein that has multiple functions including DNA damage signaling, oxygen radical metabolism, signal transduction, transcriptional regulation and apoptosis. Given the direct interaction between FANCC and UNC5A and that FANCC interferes with UNC5A-mediated apoptosis, we explored the possibility that FANCC might play a role in axonal-like growth processes. Here we show that FANCC and UNC5A are localized to regions of neurite outgrowth during neuronal cell differentiation. We also show that absence of FANCC is required for neurite outgrowth. In addition, FANCC seems required for UNC5A expression. Results from this study combined with our previous report suggest that FANCC plays a role in tissue development through the regulation of UNC5A-mediated functions.
- Open Access
- 20 July 2018
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 6 (4) , 428-434
Elevated blood levels of Dickkopf‐1 are associated with acute infections
Introduction: Dickkopf‐1 (DKK1) is a soluble protein and antagonist of the Wnt/β‐catenin signaling pathway. DKK1 is found elevated in serum from patients affected with various types of cancers and in some instances, it is considered a diagnostic and prognostic biomarker. Elevated serum levels of DKK1 have also been detected in animal models of chronic inflammatory diseases. Previous work from our laboratory has demonstrated upregulation of DKK1 in cells and mouse models of the bone marrow failure (BMF) and cancer‐prone disease Fanconi anemia (FA). The present study aimed to investigate whether DKK1 blood levels in patients are associated with FA or inflammatory responses to acute infections.Methods: Plasma samples were collected from 58 children admitted to the Centre Mère‐Enfant Soleil du Centre Hospitalier de Québec‐Université Laval with signs of acute infections. Blood plasma specimens were also collected from healthy blood donors at the Héma‐Québec blood donor clinic. Plasmas from patients diagnosed with FA were also included in the study. DKK1 levels in blood plasmas were assessed by standard ELISA.Results: Patients with acute infections showed dramatically high levels of DKK1 (6072 ± 518 pg/ml) in their blood compared to healthy blood donors (1726 ± 95 pg/ml). No correlations were found between DKK1 levels and C reactive protein (CRP) concentration, platelet numbers, or white blood cell counts. Patients with FA showed higher DKK1 plasma levels (3419 ± 147.5 pg/ml) than healthy blood donors (1726 ± 95 pg/ml) but significantly lower than patients with acute infections.Conclusion: These findings suggest that blood DKK1 is elevated in response to infections and perhaps to inflammatory responses.
- 20 July 2018
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 6 (4) , 428-434
Open AccessElevated blood levels of Dickkopf‐1 are associated with acute infections
Introduction: Dickkopf‐1 (DKK1) is a soluble protein and antagonist of the Wnt/β‐catenin signaling pathway. DKK1 is found elevated in serum from patients affected with various types of cancers and in some instances, it is considered a diagnostic and prognostic biomarker. Elevated serum levels of DKK1 have also been detected in animal models of chronic inflammatory diseases. Previous work from our laboratory has demonstrated upregulation of DKK1 in cells and mouse models of the bone marrow failure (BMF) and cancer‐prone disease Fanconi anemia (FA). The present study aimed to investigate whether DKK1 blood levels in patients are associated with FA or inflammatory responses to acute infections.Methods: Plasma samples were collected from 58 children admitted to the Centre Mère‐Enfant Soleil du Centre Hospitalier de Québec‐Université Laval with signs of acute infections. Blood plasma specimens were also collected from healthy blood donors at the Héma‐Québec blood donor clinic. Plasmas from patients diagnosed with FA were also included in the study. DKK1 levels in blood plasmas were assessed by standard ELISA.Results: Patients with acute infections showed dramatically high levels of DKK1 (6072 ± 518 pg/ml) in their blood compared to healthy blood donors (1726 ± 95 pg/ml). No correlations were found between DKK1 levels and C reactive protein (CRP) concentration, platelet numbers, or white blood cell counts. Patients with FA showed higher DKK1 plasma levels (3419 ± 147.5 pg/ml) than healthy blood donors (1726 ± 95 pg/ml) but significantly lower than patients with acute infections.Conclusion: These findings suggest that blood DKK1 is elevated in response to infections and perhaps to inflammatory responses.
- 10 July 2018
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 33 (11) , 2007-2020
Deletion of the Fanconi Anemia C Gene in Mice Leads to Skeletal Anomalies and Defective Bone Mineralization and Microarchitecture
Fanconi anemia (FA) is a rare genetic disorder associated with a progressive decline in hematopoietic stem cells leading to bone marrow failure. FA is also characterized by a variety of developmental defects including short stature and skeletal malformations. More than half of children affected with FA have radial‐ray abnormalities and many patients have early onset osteopenia/osteoporosis. Although many Fanconi anemia genes have been identified and a molecular pathway defined, the underlying mechanism leading to bone defects remains elusive. To understand the role of FA genes in skeletal development and bone microarchitecture, we evaluated bone physiology during embryogenesis and in adult FancA and FancC deficient mice. We found that both FancA‐/‐ and FancC‐/‐ embryos have abnormal skeletal development shown by skeletal malformations, growth delay and reduced bone mineralization. FancC‐/‐ adult mice present altered bone morphology and microarchitecture with a significant decrease in cortical bone mineral density in a sex‐specific manner. Mechanical testing revealed that male but not female FancC‐/‐ mice show reduced bone strength compared to their wild‐type littermates. Ex vivo cultures showed that FancA‐/‐ and FancC‐/‐ bone marrow‐derived mesenchymal stem cells (BMMSC) have impaired differentiation capabilities together with altered gene expression profiles. Our results suggest that defective bone physiology in FA occurs in utero and possibly results from altered BMMSC function. These results provide valuable insights into the mechanism involved in FA skeletal defects. This article is protected by copyright. All rights reserved
- 10 July 2018
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 33 (11) , 2007-2020
Deletion of the Fanconi Anemia C Gene in Mice Leads to Skeletal Anomalies and Defective Bone Mineralization and Microarchitecture
Fanconi anemia (FA) is a rare genetic disorder associated with a progressive decline in hematopoietic stem cells leading to bone marrow failure. FA is also characterized by a variety of developmental defects including short stature and skeletal malformations. More than half of children affected with FA have radial‐ray abnormalities and many patients have early onset osteopenia/osteoporosis. Although many Fanconi anemia genes have been identified and a molecular pathway defined, the underlying mechanism leading to bone defects remains elusive. To understand the role of FA genes in skeletal development and bone microarchitecture, we evaluated bone physiology during embryogenesis and in adult FancA and FancC deficient mice. We found that both FancA‐/‐ and FancC‐/‐ embryos have abnormal skeletal development shown by skeletal malformations, growth delay and reduced bone mineralization. FancC‐/‐ adult mice present altered bone morphology and microarchitecture with a significant decrease in cortical bone mineral density in a sex‐specific manner. Mechanical testing revealed that male but not female FancC‐/‐ mice show reduced bone strength compared to their wild‐type littermates. Ex vivo cultures showed that FancA‐/‐ and FancC‐/‐ bone marrow‐derived mesenchymal stem cells (BMMSC) have impaired differentiation capabilities together with altered gene expression profiles. Our results suggest that defective bone physiology in FA occurs in utero and possibly results from altered BMMSC function. These results provide valuable insights into the mechanism involved in FA skeletal defects. This article is protected by copyright. All rights reserved
- Open Access
- 20 February 2018
- Published by Springer Nature in BMC Research Notes
- Vol. 11 (1) , 1-7
Fanconi anemia core complex-dependent HES1 mono-ubiquitination regulates its transcriptional activity
The Hairy Enhancer of Split 1 (HES1) is a transcriptional repressor that regulates cellular proliferation and differentiation during development. We previously found an interaction between HES1 and Fanconi anemia (FA) proteins. FA is a hematological and developmental disorder caused by mutations in more than 20 different genes. Eight FA gene products form a nuclear core complex containing E3 ligase activity required for mono-ubiquitination of FANCD2 and FANCI, both of which are FA proteins. Given that HES1 interacts with members of the FA core complex, the aim of this study was to determine whether HES1 is mono-ubiquitinated via the FA core complex. We show that HES1 is mono-ubiquitinated on a highly-conserved lysine residue that is located within a FA-like recognition motif. HES1 modification is dependent on a functional FA complex. Absence of HES1 mono-ubiquitination affects transcriptional repression of its own promoter. This study uncovers a novel post-translational modification of HES1 that regulates its transcriptional activity and suggests that ubiquitination of HES1 occurs in a FA core complex-dependent manner.
- 20 February 2018
- Published by Springer Nature in BMC Research Notes
- Vol. 11 (1) , 1-7
Open AccessFanconi anemia core complex-dependent HES1 mono-ubiquitination regulates its transcriptional activity
The Hairy Enhancer of Split 1 (HES1) is a transcriptional repressor that regulates cellular proliferation and differentiation during development. We previously found an interaction between HES1 and Fanconi anemia (FA) proteins. FA is a hematological and developmental disorder caused by mutations in more than 20 different genes. Eight FA gene products form a nuclear core complex containing E3 ligase activity required for mono-ubiquitination of FANCD2 and FANCI, both of which are FA proteins. Given that HES1 interacts with members of the FA core complex, the aim of this study was to determine whether HES1 is mono-ubiquitinated via the FA core complex. We show that HES1 is mono-ubiquitinated on a highly-conserved lysine residue that is located within a FA-like recognition motif. HES1 modification is dependent on a functional FA complex. Absence of HES1 mono-ubiquitination affects transcriptional repression of its own promoter. This study uncovers a novel post-translational modification of HES1 that regulates its transcriptional activity and suggests that ubiquitination of HES1 occurs in a FA core complex-dependent manner.
- 11 July 2017
- Published by Bioscientifica in Bone Abstracts
Altered bone metabolism in Fanconi anemia results from defective mesenchymal stem cell differentiation
Fanconi anemia (FA) is a rare genetic disease associated with a progressive decline in hematopoietic stem cells leading to bone marrow failure. FA is also characterized by various developmental defects including short stature and skeletal malformations of the upper and lower limbs. Indeed, more than half of children affected with FA have radial-ray abnormalities with a tendency to early osteoporosis and osteopenia. However, the underlying mechanisms leading to bone defects in FA remains elusive. Objective: We aimed to determine the mechanism leading to altered bone development and metabolism in FA. Methods: Bone structure, mass and mineral content were evaluated using μCT-scan analyses of tibias from FancC−/− and wild-type mice. Bone’s resorption activity was determined with tartrate-resistant acid phosphatase staining. To evaluate skeletal maturation, alizarin red and Alcian blue double staining were performed on mouse embryos (E15.5 to 19.5 dpc). To assess mesenchymal stem cell differentiation ability, in-vitro cultures and qPCR analysis of bone marrow stromal cells were performed. Results: Our results show that FancC−/− mice present a 15% decrease in bone mineral content, reduced cortical thickness and diameter combined with a 15% reduction of the bone marrow area. FancC−/− mice also present elevated tartrate-resistant acid phosphatase staining as compared to wild-type littermates. In addition, FancC−/− embryos show abnormal skeletal development indicated by decreased bone length and mineralization. Using in vitro studies, we found that FancC−/− mesenchymal stem cells (MSC) have reduced osteoblastic differentiation capabilities and engraftment potential in favor of adipogenesis. Accordingly, FA-defective MSC present altered gene expression profiles of differentiation markers. Conclusion: Together, our results suggest that defective bone metabolism in FA occurs in utero and results from altered MSCs function. These results provide, for the first time, valuable insights into the mechanism involved in FA developmental defects. Disclosure The authors declared no competing interests.
- 11 July 2017
- Published by Bioscientifica in Bone Abstracts
Altered bone metabolism in Fanconi anemia results from defective mesenchymal stem cell differentiation
Fanconi anemia (FA) is a rare genetic disease associated with a progressive decline in hematopoietic stem cells leading to bone marrow failure. FA is also characterized by various developmental defects including short stature and skeletal malformations of the upper and lower limbs. Indeed, more than half of children affected with FA have radial-ray abnormalities with a tendency to early osteoporosis and osteopenia. However, the underlying mechanisms leading to bone defects in FA remains elusive. Objective: We aimed to determine the mechanism leading to altered bone development and metabolism in FA. Methods: Bone structure, mass and mineral content were evaluated using μCT-scan analyses of tibias from FancC−/− and wild-type mice. Bone’s resorption activity was determined with tartrate-resistant acid phosphatase staining. To evaluate skeletal maturation, alizarin red and Alcian blue double staining were performed on mouse embryos (E15.5 to 19.5 dpc). To assess mesenchymal stem cell differentiation ability, in-vitro cultures and qPCR analysis of bone marrow stromal cells were performed. Results: Our results show that FancC−/− mice present a 15% decrease in bone mineral content, reduced cortical thickness and diameter combined with a 15% reduction of the bone marrow area. FancC−/− mice also present elevated tartrate-resistant acid phosphatase staining as compared to wild-type littermates. In addition, FancC−/− embryos show abnormal skeletal development indicated by decreased bone length and mineralization. Using in vitro studies, we found that FancC−/− mesenchymal stem cells (MSC) have reduced osteoblastic differentiation capabilities and engraftment potential in favor of adipogenesis. Accordingly, FA-defective MSC present altered gene expression profiles of differentiation markers. Conclusion: Together, our results suggest that defective bone metabolism in FA occurs in utero and results from altered MSCs function. These results provide, for the first time, valuable insights into the mechanism involved in FA developmental defects. Disclosure The authors declared no competing interests.
- Open Access
Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?
Dickkopf-1 (DKK1) is a secreted Wnt/β-catenin pathway antagonist involved in embryogenesis. It was first described 25 years ago for its function in head induction and limb morphogenesis. Since then, this protein has been widely studied in the context of active Wnt/β-catenin signalling during cellular differentiation and development. Dysregulation of DKK1 has been associated with bone pathologies and has now emerged as a potential biomarker of cancer progression and prognosis for several types of malignancies. Reducing the amount of circulating DKK1 may reveal a simple and efficient strategy to limit or reverse cancer growth. This review will provide an overview of the role of Dickkopf-1 in cancer and explore its potential use as a biomarker and therapeutic target.
Open AccessModulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?
Dickkopf-1 (DKK1) is a secreted Wnt/β-catenin pathway antagonist involved in embryogenesis. It was first described 25 years ago for its function in head induction and limb morphogenesis. Since then, this protein has been widely studied in the context of active Wnt/β-catenin signalling during cellular differentiation and development. Dysregulation of DKK1 has been associated with bone pathologies and has now emerged as a potential biomarker of cancer progression and prognosis for several types of malignancies. Reducing the amount of circulating DKK1 may reveal a simple and efficient strategy to limit or reverse cancer growth. This review will provide an overview of the role of Dickkopf-1 in cancer and explore its potential use as a biomarker and therapeutic target.
- Open Access
- 14 October 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (10) , e0140612
The Fanconi Anemia C Protein Binds to and Regulates Stathmin-1 Phosphorylation
The Fanconi anemia (FA) proteins are involved in a signaling network that assures the safeguard of chromosomes. To understand the function of FA proteins in cellular division events, we investigated the interaction between Stathmin-1 (STMN1) and the FA group C (FANCC) protein. STMN1 is a ubiquitous cytosolic protein that regulates microtubule dynamics. STMN1 activities are regulated through phosphorylation-dephosphorylation mechanisms that control assembly of the mitotic spindle, and dysregulation of STMN1 phosphorylation is associated with mitotic aberrancies leading to chromosome instability and cancer progression. Using different biochemical approaches, we showed that FANCC interacts and co-localizes with STMN1 at centrosomes during mitosis. We also showed that FANCC is required for STMN1 phosphorylation, as mutations in FANCC reduced serine 16- and 38-phosphorylated forms of STMN1. Phosphorylation of STMN1 at serine 16 is likely an event dependent on a functional FA pathway, as it is reduced in FANCA- and FANCD2-mutant cells. Furthermore, FA-mutant cells exhibited mitotic spindle anomalies such as supernumerary centrosomes and shorter mitotic spindles. These results suggest that FA proteins participate in the regulation of cellular division via the microtubule-associated protein STMN1.
- 14 October 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (10) , e0140612
Open AccessThe Fanconi Anemia C Protein Binds to and Regulates Stathmin-1 Phosphorylation
The Fanconi anemia (FA) proteins are involved in a signaling network that assures the safeguard of chromosomes. To understand the function of FA proteins in cellular division events, we investigated the interaction between Stathmin-1 (STMN1) and the FA group C (FANCC) protein. STMN1 is a ubiquitous cytosolic protein that regulates microtubule dynamics. STMN1 activities are regulated through phosphorylation-dephosphorylation mechanisms that control assembly of the mitotic spindle, and dysregulation of STMN1 phosphorylation is associated with mitotic aberrancies leading to chromosome instability and cancer progression. Using different biochemical approaches, we showed that FANCC interacts and co-localizes with STMN1 at centrosomes during mitosis. We also showed that FANCC is required for STMN1 phosphorylation, as mutations in FANCC reduced serine 16- and 38-phosphorylated forms of STMN1. Phosphorylation of STMN1 at serine 16 is likely an event dependent on a functional FA pathway, as it is reduced in FANCA- and FANCD2-mutant cells. Furthermore, FA-mutant cells exhibited mitotic spindle anomalies such as supernumerary centrosomes and shorter mitotic spindles. These results suggest that FA proteins participate in the regulation of cellular division via the microtubule-associated protein STMN1.
- Open Access
- 27 March 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e92811
The Fanconi Anemia Group C Protein Interacts with Uncoordinated 5A and Delays Apoptosis
The Fanconi anemia group C protein (FANCC) is one of the several proteins that comprise the Fanconi anemia (FA) network involved in genomic surveillance. FANCC is mainly cytoplasmic and has many functions, including apoptosis suppression through caspase-mediated proteolytic processing. Here, we examined the role of FANCC proteolytic fragments by identifying their binding partners. We performed a yeast two-hybrid screen with caspase-mediated FANCC cleavage products and identified the dependence receptor uncoordinated-5A (UNC5A) protein. Here, we show that FANCC physically interacts with UNC5A, a pro-apoptotic dependence receptor. FANCC interaction occurs through the UNC5A intracellular domain, specifically via its death domain. FANCC modulates cell sensitivity to UNC5A-mediated apoptosis; we observed reduced UNC5A-mediated apoptosis in the presence of FANCC and increased apoptosis in FANCC-depleted cells. Our results show that FANCC interferes with UNC5A's functions in apoptosis and suggest that FANCC may participate in developmental processes through association with the dependence receptor UNC5A.
- 27 March 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e92811
Open AccessThe Fanconi Anemia Group C Protein Interacts with Uncoordinated 5A and Delays Apoptosis
The Fanconi anemia group C protein (FANCC) is one of the several proteins that comprise the Fanconi anemia (FA) network involved in genomic surveillance. FANCC is mainly cytoplasmic and has many functions, including apoptosis suppression through caspase-mediated proteolytic processing. Here, we examined the role of FANCC proteolytic fragments by identifying their binding partners. We performed a yeast two-hybrid screen with caspase-mediated FANCC cleavage products and identified the dependence receptor uncoordinated-5A (UNC5A) protein. Here, we show that FANCC physically interacts with UNC5A, a pro-apoptotic dependence receptor. FANCC interaction occurs through the UNC5A intracellular domain, specifically via its death domain. FANCC modulates cell sensitivity to UNC5A-mediated apoptosis; we observed reduced UNC5A-mediated apoptosis in the presence of FANCC and increased apoptosis in FANCC-depleted cells. Our results show that FANCC interferes with UNC5A's functions in apoptosis and suggest that FANCC may participate in developmental processes through association with the dependence receptor UNC5A.
- 27 January 2014
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 111 (6) , 2152-2157
The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression
Fanconi anemia (FA) is an inherited bone marrow failure syndrome associated with a progressive decline in hematopoietic stem cells, developmental defects, and predisposition to cancer. These various phenotypic features imply a role of FA proteins in molecular events regulating cellular homeostasis. Interestingly, we previously found that the Fanconi C protein (FANCC) interacts with the C-terminal-binding protein-1 (CtBP1) involved in transcriptional regulation. Here we report that FANCC with CtBP1 forms a complex with β-catenin, and that β-catenin activation through glycogen synthase kinase 3β inhibition leads to FANCC nuclear accumulation and FA pathway activation, as measured by the Fanconi D2 protein (FANCD2) monoubiquitination. β-catenin and FANCC nuclear entry is defective in FA mutant cells and in cells depleted of the Fanconi A protein or FANCD2, suggesting that integrity of the FA pathway is required for FANCC nuclear activity. We also report that FANCC with CtBP1 acts as a negative regulator of Dickkopf-1 (DKK1) expression, and that a FA disease-causing mutation in FANCC abrogates this function. Our findings reveal that a defective FA pathway leads to up-regulation of DKK1, a molecule involved in hematopoietic malignancies.
- 27 January 2014
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 111 (6) , 2152-2157
The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression
Fanconi anemia (FA) is an inherited bone marrow failure syndrome associated with a progressive decline in hematopoietic stem cells, developmental defects, and predisposition to cancer. These various phenotypic features imply a role of FA proteins in molecular events regulating cellular homeostasis. Interestingly, we previously found that the Fanconi C protein (FANCC) interacts with the C-terminal-binding protein-1 (CtBP1) involved in transcriptional regulation. Here we report that FANCC with CtBP1 forms a complex with β-catenin, and that β-catenin activation through glycogen synthase kinase 3β inhibition leads to FANCC nuclear accumulation and FA pathway activation, as measured by the Fanconi D2 protein (FANCD2) monoubiquitination. β-catenin and FANCC nuclear entry is defective in FA mutant cells and in cells depleted of the Fanconi A protein or FANCD2, suggesting that integrity of the FA pathway is required for FANCC nuclear activity. We also report that FANCC with CtBP1 acts as a negative regulator of Dickkopf-1 (DKK1) expression, and that a FA disease-causing mutation in FANCC abrogates this function. Our findings reveal that a defective FA pathway leads to up-regulation of DKK1, a molecule involved in hematopoietic malignancies.
- Open Access
- 7 March 2013
- Published by American Society of Hematology in Blood
- Vol. 121 (10) , 1729-1739
Fanconi anemia proteins interact with CtBP1 and modulate the expression of the Wnt antagonist Dickkopf-1
Fanconi anemia (FA) is a genetic disorder characterized by congenital abnormalities, bone marrow failure, and increased susceptibility to cancer. Of the fifteen FA proteins, Fanconi anemia group C (FANCC) is one of eight FA core complex components of the FA pathway. Unlike other FA core complex proteins, FANCC is mainly localized in the cytoplasm, where it is thought to function in apoptosis, redox regulation, cytokine signaling, and other processes. Previously, we showed that regulation of FANCC involved proteolytic processing during apoptosis. To elucidate the biological significance of this proteolytic modification, we searched for molecular interacting partners of proteolytic FANCC fragments. Among the candidates obtained, the transcriptional corepressor protein C-terminal binding protein-1 (CtBP1) interacted directly with FANCC and other FA core complex proteins. Although not required for stability of the FA core complex or ubiquitin ligase activity, CtBP1 is essential for proliferation, cell survival, and maintenance of chromosomal integrity. Expression profiling of CtBP1-depleted and FA-depleted cells revealed that several genes were commonly up- and down-regulated, including the Wnt antagonist Dickkopf-1 (DKK1). These findings suggest that FA and Wnt signaling via CtBP1 could share common effectors.
- 7 March 2013
- Published by American Society of Hematology in Blood
- Vol. 121 (10) , 1729-1739
Open AccessFanconi anemia proteins interact with CtBP1 and modulate the expression of the Wnt antagonist Dickkopf-1
Fanconi anemia (FA) is a genetic disorder characterized by congenital abnormalities, bone marrow failure, and increased susceptibility to cancer. Of the fifteen FA proteins, Fanconi anemia group C (FANCC) is one of eight FA core complex components of the FA pathway. Unlike other FA core complex proteins, FANCC is mainly localized in the cytoplasm, where it is thought to function in apoptosis, redox regulation, cytokine signaling, and other processes. Previously, we showed that regulation of FANCC involved proteolytic processing during apoptosis. To elucidate the biological significance of this proteolytic modification, we searched for molecular interacting partners of proteolytic FANCC fragments. Among the candidates obtained, the transcriptional corepressor protein C-terminal binding protein-1 (CtBP1) interacted directly with FANCC and other FA core complex proteins. Although not required for stability of the FA core complex or ubiquitin ligase activity, CtBP1 is essential for proliferation, cell survival, and maintenance of chromosomal integrity. Expression profiling of CtBP1-depleted and FA-depleted cells revealed that several genes were commonly up- and down-regulated, including the Wnt antagonist Dickkopf-1 (DKK1). These findings suggest that FA and Wnt signaling via CtBP1 could share common effectors.